ClinicalTrials.gov
public full text
Public Domain
Effect of Renal Impairment on Enpatoran Pharmacokinetics
The purpose of this study is to assess the effect of renal impairment on the pharmacokinetics of enpatoran.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function#847410
- A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function#1073323
- A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy Participants#870077
- Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects#1372565
- A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects#1111939
Record · ID 1182435
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive